Evidence map›Paper›PMID 35292784›Full record

ArticleNature cell biology2022

Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome.

Nicola Guzzi, Sowndarya Muthukumar, Maciej Cieśla, Gabriele Todisco, Phuong Cao Thi Ngoc, Magdalena Madej, Roberto Munita, Serena Fazio, Simon Ekström, Teresa Mortera-Blanco and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Pseudouridine synthase 7 as a context-specific therapeutic target in cancer.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  5. Review
  6. Review
  7. mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Nicola Guzzi *Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Sowndarya Muthukumar *Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-9110-722X
Maciej Cieśla *Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Gabriele TodiscoCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-6583-3829
Phuong Cao Thi NgocDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-3059-9179
Magdalena MadejDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0003-3821-3514
Roberto MunitaDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Serena FazioDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Simon EkströmBioMS-Swedish National Infrastructure for Biological Mass Spectrometry, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-7694-285X
Teresa Mortera-BlancoCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Monika JanssonCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Yasuhito NannyaDepartment of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
Mario CazzolaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0001-6984-8817
Seishi OgawaCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
Luca MalcovatiDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0002-1460-1611
Eva Hellström-LindbergCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7839-3743
Marios DimitriouCenter for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institute, Stockholm, Sweden. marios.dimitriou@ki.se.ORCID http://orcid.org/0000-0001-8362-2099
Cristian BellodiDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden. cristian.bellodi@med.lu.se.ORCID http://orcid.org/0000-0001-8047-5329
Lund University · SEKarolinska Institutet · SEUniversity of Pavia · ITKyoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transfer RNA-derived fragments (tRFs) are emerging small noncoding RNAs that, although commonly altered in cancer, have poorly defined roles in tumorigenesis

Indexed as

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesHematopoietic Stem CellsHumansPeptide Initiation FactorsPseudouridineRNA-Binding ProteinsRNA, TransferPAIP1 protein, humanPeptide Initiation FactorsPseudouridineRNA-Binding ProteinsRNA, Transfer

Identifiers

PMID35292784
PMCPMC8924001
OpenAlexW4220965395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.